Vivozon Healthcare Inc (082800) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.011x

Based on the latest financial reports, Vivozon Healthcare Inc (082800) has a cash flow conversion efficiency ratio of -0.011x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.10 Billion ≈ $-742.54K USD) by net assets (₩95.30 Billion ≈ $64.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 082800 market cap overview for the company's overall valuation and market capitalisation.

Vivozon Healthcare Inc - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Vivozon Healthcare Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Vivozon Healthcare Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vivozon Healthcare Inc ranked by their cash flow conversion efficiency. Explore Vivozon Healthcare Inc (082800) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Shinhan Seobu T&D REIT Co Ltd KO:404990	N/A
Fong Chien Construction Co Ltd TWO:5523	-0.103x
Amber International Holding Limited NYSE:AMBR	0.226x
LG Household & Healthcare Ltd Pref KO:051905	0.029x
Mayur Resources Ltd AU:MRL	-0.090x
Indigo Acquisition Corp. Ordinary Shares NASDAQ:INAC	0.265x
Dana Brata Luhur PT JK:TEBE	0.009x
LBS Bina Group Bhd KLSE:5789	0.025x

Annual Cash Flow Conversion Efficiency for Vivozon Healthcare Inc (2014–2025)

The table below shows the annual cash flow conversion efficiency of Vivozon Healthcare Inc from 2014 to 2025. View 082800 live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩72.66 Billion ≈ $49.24 Million	₩-6.87 Billion ≈ $-4.65 Million	-0.095x	-275.53%
2024-12-31	₩106.43 Billion ≈ $72.12 Million	₩5.73 Billion ≈ $3.88 Million	0.054x	+87.33%
2023-12-31	₩104.07 Billion ≈ $70.52 Million	₩2.99 Billion ≈ $2.03 Million	0.029x	+191.55%
2022-12-31	₩105.84 Billion ≈ $71.72 Million	₩-3.32 Billion ≈ $-2.25 Million	-0.031x	+84.72%
2021-12-31	₩85.12 Billion ≈ $57.68 Million	₩-17.50 Billion ≈ $-11.86 Million	-0.206x	-579.12%
2020-12-31	₩107.80 Billion ≈ $73.06 Million	₩4.62 Billion ≈ $3.13 Million	0.043x	+220.09%
2019-12-31	₩109.00 Billion ≈ $73.87 Million	₩-3.89 Billion ≈ $-2.64 Million	-0.036x	+46.71%
2018-12-31	₩68.45 Billion ≈ $46.38 Million	₩-4.59 Billion ≈ $-3.11 Million	-0.067x	+76.48%
2017-12-31	₩16.10 Billion ≈ $10.91 Million	₩-4.59 Billion ≈ $-3.11 Million	-0.285x	-210.44%
2016-12-31	₩22.74 Billion ≈ $15.41 Million	₩5.87 Billion ≈ $3.98 Million	0.258x	+128.52%
2015-12-31	₩24.65 Billion ≈ $16.71 Million	₩2.78 Billion ≈ $1.89 Million	0.113x	+26.48%
2014-12-31	₩33.90 Billion ≈ $22.97 Million	₩3.03 Billion ≈ $2.05 Million	0.089x	--

About Vivozon Healthcare Inc

KQ:082800 Korea Pharmaceuticals

Market Cap

$148.10 Million

₩218.54 Billion KRW

Market Cap Rank

#17793 Global

#746 in Korea

Share Price

₩2935.00

Change (1 day)

+2.09%

52-Week Range

₩2155.00 - ₩7120.00

All Time High

₩16500.00